IMDX vs UNP · rev $271.0K vs P/E 21, rev $6.86B
Insight Molecular Diagnostics Inc. (IMDX) versus Union Pacific Corporation (UNP) — a side-by-side from cached financials, not a winner call.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Union Pacific Corporation (UNP) is a railroads company listed on NYSE.
Latest reported IMDX revenue for 2026-06-30 was $271.0K. Net income was -$15.6M. IMDX currently screens at market cap $0.
Latest reported UNP revenue for 2026-06-30 was $6.86B. Net income was $1.99B. Revenue was up 10.4% from 2026-03-31 to 2026-06-30. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
IMDX currently screens at market cap $0. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
Not investment advice. Open the IMDX and UNP stock pages for the full models.
Not investment advice.